Preview Mode Links will not work in preview mode

Rheum Advisor on Air

Sep 9, 2021

The recent US Food and Drug Administration (FDA) approval of anifrolumab for the treatment of systemic lupus erythematosus (SLE) came a decade after the approval of human monoclonal antibody belimumab.

In this episode of the Rheumatology Advisor podcast, we speak with Mary K. Crow, MD, who provides a deeper insight into...